William R. White J.D.
Net Worth

Last updated:

What is William R. White J.D. net worth?

The estimated net worth of Mr. William R. White J.D. is at least $14,597,505 as of 10 Dec 2024. He owns shares worth $1,820,913 as insider, has earned $10,319,992 from insider trading and has received compensation worth at least $2,456,600 in Akero Therapeutics, Inc..

What is the salary of William R. White J.D.?

Mr. William R. White J.D. salary is $614,150 per year as Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporation Devel. in Akero Therapeutics, Inc..

How old is William R. White J.D.?

Mr. William R. White J.D. is 52 years old, born in 1973.

What stocks does William R. White J.D. currently own?

As insider, Mr. William R. White J.D. owns shares in one company:

Company Title Shares Price per share Total value
Akero Therapeutics, Inc. (AKRO) Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporation Devel. 38,335 $47.5 $1,820,913

What does Akero Therapeutics, Inc. do?

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

AKRO logo
AKRO
Akero Therapeutics, Inc.
$47.5

William R. White J.D. insider trading

Akero Therapeutics, Inc.

Mr. William R. White J.D. has made 26 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,817 units of AKRO stock worth $86,735 on 10 Dec 2024.

The largest trade he's ever made was exercising 139,083 units of AKRO stock on 24 Jul 2024. As of 10 Dec 2024 he still owns at least 38,335 units of AKRO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,817 $30.79 $86,735
Sale
Common Stock 639 $26.18 $16,729
Sale
Common Stock 23,175 $26.41 $612,098
Option
Common Stock 23,175 $21.09 $488,761
Option
Stock Option (Right to Buy) 23,175 $21.09 $488,761
Option
Stock Option (Right to Buy) 18,116 $21.09 $382,066
Option
Stock Option (Right to Buy) 32,671 $7.01 $228,991
Option
Stock Option (Right to Buy) 24,372 $19.87 $484,272
Option
Common Stock 24,372 $19.87 $484,272
Option
Common Stock 18,116 $21.09 $382,066
Option
Common Stock 32,671 $7.01 $228,991
Sale
Common Stock 18,116 $27.21 $492,954
Option
Common Stock 22,272 $7.01 $156,104
Sale
Common Stock 1,791 $27 $48,357
Sale
Common Stock 59,637 $26.71 $1,592,904
Option
Stock Option (Right to Buy) 139,083 $7.01 $974,833
Option
Common Stock 139,083 $7.01 $974,833
Option
Stock Option (Right to Buy) 500 $7.01 $3,505
Option
Common Stock 500 $7.01 $3,505
Sale
Common Stock 724 $28.33 $20,511
Sale
Common Stock 611 $20.76 $12,684
Option
Common Stock 17,500 $7.01 $122,658
Sale
Common Stock 20,777 $55 $1,142,735
Option
Stock Option (Right to Buy) 17,500 $7.01 $122,658
Sale
Common Stock 606 $55.16 $33,427
Option
Stock Option (Right to Buy) 999 $7.01 $7,002
Option
Common Stock 999 $7.01 $7,002
Sale
Common Stock 999 $49.76 $49,714
Option
Common Stock 19,001 $7.01 $133,178
Option
Stock Option (Right to Buy) 19,001 $7.01 $133,178
Sale
Common Stock 19,001 $49.77 $945,604
Option
Stock Option (Right to Buy) 20,000 $7.01 $140,180
Sale
Common Stock 20,000 $39.82 $796,400
Option
Common Stock 20,000 $7.01 $140,180
Sale
Common Stock 18,920 $26.42 $499,866
Sale
Common Stock 13,580 $27.87 $378,475
Option
Stock Option (Right to Buy) 32,500 $7.01 $227,793
Option
Common Stock 32,500 $7.01 $227,793
Option
Common Stock 9,700 $7.01 $67,987
Sale
Common Stock 9,700 $22.03 $213,691
Option
Stock Option (Right to Buy) 9,700 $7.01 $67,987
Option
Common Stock 100 $7.01 $701
Option
Stock Option (Right to Buy) 100 $7.01 $701
Sale
Common Stock 100 $22 $2,200
Sale
Common Stock 3,200 $22.04 $70,528
Option
Stock Option (Right to Buy) 3,200 $7.01 $22,429
Option
Common Stock 3,200 $7.01 $22,429
Sale
Common Stock 6,500 $22.24 $144,560
Option
Common Stock 6,500 $7.01 $45,559
Option
Stock Option (Right to Buy) 6,500 $7.01 $45,559
Option
Stock Option (Right to Buy) 6,500 $7.01 $45,559
Sale
Common Stock 6,500 $22.06 $143,364
Option
Common Stock 6,500 $7.01 $45,559
Sale
Common Stock 8,559 $7.01 $59,990
Option
Stock Option (Right to Buy) 8,559 $7.01 $59,990
Option
Common Stock 8,559 $7.01 $59,990
Option
Stock Option (Right to Buy) 4,441 $7.01 $31,127
Option
Common Stock 4,441 $7.01 $31,127
Sale
Common Stock 4,441 $7.01 $31,127
Sale
Common Stock 6,500 N/A N/A
Option
Stock Option (Right to Buy) 6,500 N/A N/A
Option
Common Stock 6,500 N/A N/A
Option
Stock Option (Right to Buy) 4,200 $7.01 $29,438
Sale
Common Stock 4,200 $7.01 $29,438
Option
Common Stock 4,200 $7.01 $29,438
Sale
Common Stock 50,000 $28.96 $1,447,950
Option
Common Stock 50,000 $7.01 $350,500
Option
Stock Option (Right to Buy) 50,000 $7.01 $350,500
Sale
Common Stock 50,000 $28.96 $1,447,950

Akero Therapeutics key executives

Akero Therapeutics, Inc. executives and other stock owners filed with the SEC: